Klaus Lindblad

Direktor/Vorstandsmitglied bei WASTE PLASTIC UPCYCLING AS

Vermögen: 5 Mio $ am 30.04.2024

Utilities

Industrial Services

Finance

Aktive Positionen von Klaus Lindblad

Unternehmen	Position	Beginn	Ende
WASTE PLASTIC UPCYCLING AS	Direktor/Vorstandsmitglied	19.11.2020	-
WASTE PLASTIC UPCYCLING AS	General Counsel	19.11.2020	-
DKA Consult A/S DKA Consult A/S Electric UtilitiesUtilities DKA Consult A/S operates as a holding company with interest in renewable energy. The company was founded in 1991 and is headquartered in Holbæk, Denmark	Vorsitzender	04.03.2011	-

Unternehmen	Position	Beginn	Ende
SERENDEX PHARMACEUTICALS A/S	Direktor/Vorstandsmitglied	-	-
Nordic Development SA Nordic Development SA Real Estate DevelopmentFinance Nordic Development SA develops and operates on the polish real estate market. It intends to implementation of development projects distinctive architecture. The company business includes the investment and multi-service centers. Nordic Development was founded in 2006 and is headquartered in Bydgoszcz, Poland.	Vorsitzender	-	-

University of Copenhagen

Graduate Degree

International

Dänemark	5
Polen	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
WASTE PLASTIC UPCYCLING AS	Industrial Services

Private Unternehmen	3
DKA Consult A/S DKA Consult A/S Electric UtilitiesUtilities DKA Consult A/S operates as a holding company with interest in renewable energy. The company was founded in 1991 and is headquartered in Holbæk, Denmark	Utilities
Nordic Development SA Nordic Development SA Real Estate DevelopmentFinance Nordic Development SA develops and operates on the polish real estate market. It intends to implementation of development projects distinctive architecture. The company business includes the investment and multi-service centers. Nordic Development was founded in 2006 and is headquartered in Bydgoszcz, Poland.	Finance
Serendex Pharmaceuticals A/S Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark.	Health Technology